Fervex: instructions for use, price, reviews for children, composition and analogues

Pharmacodynamics and pharmacokinetics

The effect of this combination drug is determined by the components that are present in its composition.

Paracetamol is able to exhibit an analgesic and antipyretic effect by influencing central thermoregulation in the hypothalamus. This also lowers body temperature and eliminates headaches and other painful sensations.

Ascorbic acid is one of the regulators of redox processes, tissue regeneration, GCS production, blood , carbohydrate metabolism, procollagen and collagen , and helps normalize capillary permeability. The use of this vitamin increases the body's resistance by stimulating the immune system.

The substance pheniramine is a H1-histamine receptor blocker. With its help, the manifestations of rhinorrhea, nasal congestion, lacrimation, sneezing, redness and itching of the eyes are reduced.

Inside the body, the drug undergoes rapid and complete absorption. Its maximum concentration in plasma is detected 30-60 minutes after application. Good distribution in tissues and physiological fluids, but also penetration through the BBB was noted. The connection with plasma proteins is completely insignificant. Metabolism occurs within the liver, resulting in the formation of inactive metabolites . The components of Fervex are excreted through the kidneys.

Pharmacokinetics

Fervex for children

Paracetamol.

Absorption of paracetamol is complete and rapid. Peak plasma concentrations are reached 30–60 minutes after administration. The distribution of paracetamol in tissues occurs quickly. Comparable drug concentrations are achieved in blood, saliva and plasma. Plasma protein binding is low, 10–25%. Penetrates through the BBB.

Metabolism occurs in the liver, 80% enters into conjugation reactions with glucuronic acid and sulfates to form inactive metabolites; 17% undergoes hydroxylation to form 8 active metabolites, which conjugate with glutathione to form inactive metabolites. With a lack of glutathione, these metabolites can block the enzyme systems of hepatocytes and cause their necrosis. The isoenzyme CYP2E1.T1/2 is also involved in the metabolism of the drug - 1–4 hours. It is excreted by the kidneys in the form of metabolites, mainly conjugated. Less than 5% is excreted unchanged.

Pheniramine maleate.

Well absorbed from the digestive tract. T1/2 from blood plasma is 1–1.5 hours. It is excreted from the body mainly through the kidneys.

Ascorbic acid.

Well absorbed from the digestive tract. Tmax after oral administration is 4 hours. Metabolized primarily in the liver. It is excreted by the kidneys, through the intestines, with sweat - unchanged and in the form of metabolites.

Contraindications

Contraindications to the use of Fervex:

sensitivity to the drug;
erosions and ulcers of the gastrointestinal tract;
renal failure;
alcoholism;
portal hypertension;
deficiency of the enzyme glucose-6-phosphate dehydrogenase;
age up to 15 years;
lactation, pregnancy.

Fervex for children is contraindicated for:

sensitivity to it;
severe liver and kidney disorders;
lactation , pregnancy ;
deficiency of the enzyme glucose-6-phosphate dehydrogenase;
blood diseases;
children under 6 years of age.

Use with extreme caution is allowed for benign hyperbilirubinemia and diabetes mellitus .

special instructions

Fervex

If you are taking metoclopramide, domperidone or cholestyramine, you should also consult your doctor.

It is possible to distort laboratory test results when quantifying the concentration of uric acid and glucose in plasma. To avoid toxic liver damage, paracetamol should not be combined with alcoholic beverages, or taken by persons prone to chronic alcohol consumption. The risk of developing liver damage increases in patients with alcoholic hepatosis.

If the drug is taken by patients suffering from diabetes or on a low-sugar diet, it should be taken into account that each sachet contains 11.5 g of sugar, which corresponds to 0.9 XE.

Additionally for Fervex lemon without sugar: the drug does not contain sugar and can be used by patients suffering from diabetes.

Fervex for children

The drug should not be used simultaneously with other medications containing paracetamol.

When using the drug for more than a week, monitoring the functional state of the liver and peripheral blood patterns is necessary.

If the drug is taken by children with diabetes or on a low-sugar diet, it should be taken into account that each sachet contains 2.4 g of sucrose.

Paracetamol distorts the results of laboratory tests of glucose and uric acid in blood plasma.

If there is no therapeutic effect (fever persists for more than 3 days and pain persists for more than 5 days), a doctor’s consultation is required.

Side effects

When treated with Fervex, side effects develop quite rarely, especially if you follow the recommended dosages. However, the manifestation of: nausea, abdominal pain, allergic reactions - skin rash, itching, urticaria, Quincke's edema is possible.

Side effects

Fervex

Fervex for children

The drugs are well tolerated in recommended doses.

Nausea, pain in the epigastric region, allergic reactions (skin rash, itching, urticaria, Quincke's edema).

Rarely - hematopoietic disorders (anemia, thrombocytopenia, methemoglobinemia), dry mouth, accommodation paresis, urinary retention, drowsiness. With long-term use (in doses significantly higher than recommended), the likelihood of liver and kidney dysfunction increases; monitoring of the peripheral blood picture is necessary. All side effects of the drug should be reported to your doctor. If adverse reactions occur, you should stop taking the drug and consult a doctor.

Instructions for use of Fervex (Method and dosage)

This drug is intended for oral administration. First, the contents of the sachet are completely dissolved in a glass of water and immediately drunk. The optimal time to take it is between meals.

It is recommended to take 1 sachet no more than 2-3 times a day. In this case, an interval of 4 hours must be observed. For elderly patients and those suffering from liver or kidney disorders, this interval is 8 hours.

The course of treatment is no more than 5 days.

Instructions for use of Fervex for children also recommend taking it orally, after thoroughly dissolving the powder in 200 ml of water.

In this case, children's Fervex is prescribed taking into account the age of the small patient. Therefore, Fervex for children 6-10 years old is recommended in a daily dosage of 1 sachet for 2 doses. At the age of 10-12 years you can take one sachet 3 times a day, and at 12-15 years old - one sachet up to 4 times a day.

The instructions for children advise maintaining an interval of 4 hours between doses. The duration of therapy is no more than 3 days.

Terms of use

This agreement governs the relations arising between the Portal “apteka9800000” and users of the Internet site www.apteka9800000.ru.

1. General Provisions

1.1. The portal “apteka9800000” (hereinafter referred to as the “Portal”) offers Internet users (hereinafter referred to as the “User”) its Services and the services of the website www.apteka9800000.ru (hereinafter referred to as the “Site”) on the terms and conditions set forth in this Agreement.

1.2. The use of the Site services, as well as all relations between the Pharmacy Chain and the User related to the use of the Site services, are governed by this Agreement.

1.3. By using the services of the Site, the User agrees with all the terms of this Agreement, as well as those set out on the pages of the Site, undertakes to comply with them, and in case of disagreement with any of the conditions, immediately stop using the services of the Site.

1.4. This Agreement applies to all currently existing services of the Site, as well as to any development thereof and/or addition of new services.

1.5. Nothing in the Agreement can be understood as the establishment between the User and the Pharmacy Network of agency relations, partnership relations (joint activities), or any other relations not expressly provided for in this Agreement.

1.6. This Agreement is governed by the civil legislation of the Russian Federation.

1.7. All possible disputes regarding this Agreement and the relationship between the Pharmacy Chain and the User will be resolved in accordance with Russian law.

1.8. Recognizing any provision of the Agreement as invalid or unenforceable does not entail the invalidity or unenforceability of other provisions of the Agreement.

1.9. Inaction on the part of the Pharmacy Network in the event of a violation by the User of the provisions of the Agreement does not deprive the Pharmacy Network of the right to take appropriate actions to protect its interests later, and also does not mean that the Pharmacy Network waives its rights in the event of subsequent commission of similar or similar violations.

1.10. The Portal reserves the right to change this Agreement without any special notice. The new version of the Agreement comes into force from the moment it is posted on this website, unless otherwise provided by the new version of the Agreement.

1.11. The portal recommends that persons under 18 years of age refrain from accessing the services of the Site. The Portal does not intentionally collect information received from minors, including the latter’s personal data, and does not use or target the content of the Site to minors. Responsibility for the actions of minors, including their purchase of Products from the Pharmacy Chain catalog on the Site, lies with the legal representatives of minors.

1.12. A link (in any form) to any site, product, service, any information of a commercial or non-commercial nature posted on the Site does not constitute an endorsement or recommendation of these products (services, activities) by "apteka9800000", except in cases where this is directly indicated on the resources “apteka9800000”.

2. Description of the Services offered when using the Site

2.1. The Portal offers the Site User a range of services, including tools for searching for information, ordering and making purchases.

2.2. The Portal delivers the Goods using the methods indicated on the Site.

2.3. The Portal provides access to the services of the Site to obtain information on the Product of interest to the User.

2.4. Information about the consumer properties, cost and quantity of goods in the Pharmacy Chain is presented for informational purposes. The exact cost, instructions for use, description of the goods, and the size of the discount can be found out at the time of purchase at the pharmacy. The image on the website may differ slightly from the appearance of the product.

3. Registration, authorization and security

3.1. Registration on the Pharmacy Network Website provides the User with a non-transferable right to use his authorization code, which is a unique symbolic name of the User’s account. An authorization code is provided to the User to access the services of the Site, as well as to make purchases from the Pharmacy Chain catalog on the Site. The portal has the right to set requirements for login and password (length, character tolerance, etc.).

3.2. The User is responsible for the security of his authorization code, as well as for everything that will be done using the services of the Pharmacy Network under the User’s authorization.

3.3. The user independently carries out a secure shutdown of work using his authorization code at the end of each session of working with the Site services and undertakes to ensure the confidentiality of his authorization code for the Site services.

3.4. The user does not have the right to transfer his authorization code to third parties, and also does not have the right to receive it from third parties. The Portal does not bear any responsibility for transactions between the User and third parties using the services of the Site under its authorization.

3.5. The User is obliged to immediately notify the Pharmacy Network of any case of unauthorized access to his authorization code and/or of any violation of the security of his Personal Account on the Pharmacy Network Website.

3.6. The Portal reserves the right to delete the User’s account if the User has not used his access to the Site’s services for quite a long time. The determination of insufficient account activity in each specific case remains at the discretion of the Pharmacy Network.

3.7. The Site services may contain links to other resources. The Portal does not bear any responsibility for the availability of these resources and their content, as well as for any consequences associated with the User’s use of the content of these resources.

3.8. The Portal does not bear any responsibility for the User’s personal data, which the User provides to third-party resources and/or other third parties in the event of a transition to them from the Pharmacy Chain Website.

3.9. The Portal is not responsible for possible loss and/or damage to data that may occur due to the User’s violation of the provisions of this Agreement, as well as improper access and/or use of the Site’s services.

4. Obligations of the User upon Registration

4.1. To purchase Products from the Pharmacy Chain catalog on the Site, as well as to access other services of the Site, the User provides reliable and complete information on the issues offered during Registration, and necessary to fulfill the obligations of the Pharmacy Chain in relation to the Product purchased by the User and/or the User’s access to the services of the Site. The user also undertakes to keep this information up to date.

5. Obligations of the User when using the services of the Site

5.1. The User undertakes not to use the Site services for the purpose of:

5.1.1. impersonating another person or representative of an organization and/or community without sufficient rights;

5.1.2. disruption of the normal operation of the Pharmacy Chain Website.

5.2. The User acknowledges and agrees that the Portal has the right, at its own discretion, to refuse to post and/or delete any content available through the Site’s services.

5.3. When ordering Products related to medicines dispensed with a doctor's prescription, at the time of purchase, provide and transfer to a representative of the Pharmacy Chain a prescription in the established form. If the prescription submitted by the User does not comply with the requirements of the current legislation, the Pharmacy Chain will not dispense medicines.

6. Information support for the User

6.1. The User hereby gives your voluntary consent to be informed about all actions of the Pharmacy Chain related to the provision of Services, including the status of the Order, as well as other events of any nature related to the services of the Site. For example, to inform about promotions, sales, opening hours, and contact numbers of the pharmacy chain.

6.2. The User hereby gives his voluntary consent to be informed about news, promotions and other offers of the Pharmacy Network by sending personalized notifications, which can be sent to the email address provided by the User at the time of Registration or at the time of placing an order on the Site, and/or SMS notifications to your mobile phone number.

6.3. If at any time the user wishes to stop receiving mailings, the user can refuse to receive them by calling the help desk of the portal www.apteka9800000.ru and reporting his desire. If “apteka9800000” has made any changes to the Agreement with which the User does not agree, he is obliged to stop using the “apteka9800000” services.

6.4. The User agrees that the Portal does not bear any responsibility for delays, failures, incorrect or untimely delivery, deletion or failure to store any notices. At the same time, the Portal reserves the right to re-send any notification if it is not received by the User.

6.5. The User can ask all questions regarding information support to the customer support service by e-mail: .

6.6. The user is informed and agrees that prices in pharmacies may differ from the prices indicated on the website. Prices on the website are for informational purposes only and under no circumstances constitute a public offer as defined by the provisions of clause 2 of Art. 437 Civil Code of the Russian Federation. For detailed information about current prices for goods and the availability of goods in a particular pharmacy, please contact the helpline.

7. Termination of User Registration

7.1. The User agrees that the Portal reserves the right to block and/or delete his account, or terminate his account in relation to any services of the Site if the User violates any of the provisions of this Agreement.

8. Copyright Pharmacy Chain

8.1. The User agrees that the content provided to him in the process of using the Site services belongs to the Pharmacy Network and is protected by the relevant regulatory legal acts in force in the Russian Federation.

8.2. The user does not have the right to reproduce, copy or process the services of the Site, as well as use any parts of them for personal or commercial purposes.

9. Terms of information processing

9.1. The User hereby agrees that his use of the Site Services means his unconditional consent to the provision and processing of his personal data by the Pharmacy Network.

9.2. The user acknowledges that his consent to the processing of personal data given by him to the Pharmacy Network applies to all affiliates of the Pharmacy Network.

9.3. Consent to the processing of personal data is valid for the duration of the existence of the portal “apteka9800000”.

10. About the return and exchange of goods

10.1. The User is hereby informed that in accordance with the Federal Law of the Russian Federation dated 02/07/1992 No. 2300-1 “On the Protection of Consumer Rights” and the Decree of the Government of the Russian Federation dated 01/19/1998. No. 55 goods for the prevention and treatment of diseases at home (sanitary and hygiene items made of metal, rubber, textiles and other materials, medical instruments, instruments and equipment, oral hygiene products, spectacle lenses, child care items), medicines ; personal hygiene items (toothbrushes, combs, hairpins, hair curlers, wigs, hairpieces and other similar products); perfumery and cosmetic products are not subject to return or exchange for a similar product.

10.2. The User hereby confirms that he has read, understood and fully agrees with all the terms and conditions for the provision of the Pharmacy Network Services.

Overdose

When taking Fervex for a long time in an increased dosage, symptoms such as pale skin, decreased appetite , hepatonecrosis, nausea, and vomiting may appear. , liver failure may occur .

Treatment includes mandatory measures in such cases: gastric lavage, use of SH-group donors or precursors for the production of glutathione-methionine 8-9 hours after the overdose. If the overdose period is 12 hours, then N-acetylcysteine is administered. At the same time, other accompanying measures are carried out, which depend on the symptoms that appear.

Interaction

Combination with antidepressants, antiparkinsonian and antipsychotic drugs may increase the risk of side effects.

Simultaneous use with inducers of microsomal oxidation in the liver, for example, with Phenytoin, barbiturates, Rifampicin, Phenylbutazone and tricyclic antidepressants , can increase the production of hydroxylated active metabolites, which may result in the development of severe intoxications .

Fervex's analogues

Level 4 ATC code matches:
Phenacetin

Combiflu

Chlorphenamine

Coldflu

Calpol

Panadol Extra

Panadol for children

Panadol

Solpadeine

Efferalgan

Milistan

Coldrex Maxgripp

Coldrex Hotrem

Coldrex

AntiGrippin

Unispaz

Pentalgin Plus

Rapidol

Maxicold

Perfalgan

The main analogues of Fervex: Bioparox, Sinupret, Teraflu, Coldrex.

Which is better – Fervex or Theraflu?

Each of these drugs has a similar composition and indications for use. However, Theraflu effect is not reduced.

In this case, the antipyretic and analgesic effect manifests itself almost equally.

What is Fervex?

The drug Fervex is a dry powder for preparing a solution, which includes:

Paracetamol is an antipyretic, analgesic and anti-inflammatory agent.
Ascorbic acid or vitamin C is a supplement that strengthens the walls of blood vessels and improves immunity.
Pheniramine is an antihistamine (antiallergic) component.

The main substance in the drug is paracetamol, the action of which does not pose a danger to the developing fetus from a certain stage of development.

It can be argued that Fervex is a mixture of regular paracetamol and ascorbic acid in powder, packaged in bright packaging.

Pheniramine has antiallergic properties, eliminates nasal congestion and itching, but it does not cure, but blocks severe symptoms. Doctors do not have reliable information about the safety of Fervex during pregnancy, so you should not use it often.

Reviews about Fervex

There are a lot of reviews about Fervex on medical forums. According to users, if you take this drug at the first sign of a cold, the development of the disease can be quickly stopped. At the same time, great importance is given to bed rest, drinking plenty of fluids and proper rest - all this, together with the drug, provides good support to the body, increasing its resistance to viral infection.

Users often discuss Fervex for children, which can be taken by young patients from 6 years of age. At this age, it is difficult for children to give pills, but they take drugs in the form of suspensions, sweet solutions and syrups more willingly. The effectiveness of this drug is also maximal when it is started when the first symptoms of the disease appear.

Among the positive opinions, there are reviews of Fervex that report the development of side effects. drowsiness is especially often mentioned , which, however, is also typical for viral infections.

You can also find reports that treatment with this drug turned out to be completely useless. After therapy for several days, the cold symptoms not only did not decrease, but, on the contrary, became more complicated. In addition, inflammation in the throat, muscle aches and headaches increased.

Unfortunately, many people consider colds to be commonplace and do not make special efforts to treat them. They often try to suppress the symptoms that appear, but this approach often leads to complications, the treatment of which requires radical measures, including taking antibiotics .

Therefore, if it was not possible to reduce the manifestation of a cold within 2-3 days, you need to consult a doctor. The specialist will prescribe appropriate medications and additional examination, which will help to achieve a quick recovery.

Fervex

Fervex por d/prig solution vn lemon with sugar 500 mg+25 mg+200 mg x8 Release form, packaging and composition of Fervex®

Powder for preparing a solution for oral administration (lemon with sugar) is light beige in color, inclusions of brown are allowed, the prepared solution is light yellow with a grayish tint, opalescent.

1 pack

paracetamol 500 mg

pheniramine maleate 25 mg

ascorbic acid 200 mg

Excipients: sucrose - 11.555 g, citric acid - 0.2 g, acacia gum - 0.1 g, sodium saccharinate dihydrate - 0.02 g, lemon-rum flavoring * - 0.5 g.

Powder for preparing a solution for oral administration (raspberry with sugar) from light pink to light beige, dark pink inclusions are allowed, the prepared solution is pink, slightly opalescent.

1 pack

paracetamol 500 mg

pheniramine maleate 25 mg

ascorbic acid 200 mg

Excipients: sucrose - 11.555 g, citric acid - 0.2 g, acacia gum - 0.1 g, sodium saccharinate dihydrate - 0.02 g, raspberry flavor** - 0.15 g.

* composition of lemon-rum flavor: maltodextrin, acacia gum, α-pinene, β-pinene, limonene, γ-terpinene, linalool, neral, α-terpineol, geranial, dextrose, silicon dioxide, butylated hydroxyanisole. ** composition of raspberry flavor: ethyl acetate, isoamyl acetate, acetic acid, benzyl alcohol, triacetin, vanillin, p-hydroxy-benzylacetone, maltodextrin, E1450 modified corn starch, E129 charming red dye, E133 brilliant blue dye, E110 sunset yellow dye, permastabil 505528 RI, raspberry 054428 A, sodium chloride and/or sodium sulfate.

Clinical-pharmacological group: Drug for symptomatic treatment of acute respiratory diseases Pharmaco-therapeutic group: Drug for eliminating the symptoms of acute respiratory infections and “colds” (analgesic non-narcotic drug + vitamin + H1-histamine receptor blocker)

pharmachologic effect

Fervex® is a combination drug that contains paracetamol, pheniramine and ascorbic acid.

Paracetamol is a non-narcotic analgesic that blocks cyclooxygenase, mainly in the central nervous system, affecting the centers of pain and thermoregulation, and has an analgesic and antipyretic effect.

Pheniramine is a histamine H1 receptor blocker, reduces rhinorrhea and lacrimation, eliminates spastic phenomena, swelling and hyperemia of the mucous membrane of the nasal cavity, nasopharynx and paranasal sinuses.

Ascorbic acid is a cofactor in some hydroxylation and amidation reactions - it transfers electrons to enzymes, providing them with a reducing equivalent. Participates in the reactions of hydroxylation of proline and lysine residues of procollagen with the formation of hydroxyproline and hydroxylysine (post-translational modification of collagen), oxidation of lysine side chains in proteins with the formation of hydroxytrimethyllysine (in the process of carnitine synthesis), oxidation of folic acid to folinic acid, metabolism of drugs in liver microsomes and hydroxylation dopamine to form norepinephrine. Increases the activity of amidating enzymes involved in the synthesis of oxytocin, adrenocorticotropic hormone and cholecystokinin. Participates in steroidogenesis in the adrenal glands.

Pharmacokinetics

Paracetamol

Absorption is high. The time required to achieve the maximum concentration (TCmax) is 30-60 minutes, the maximum concentration (Cmax) is 5-20 μg/ml. Plasma protein binding - 15%. Penetrates the blood-brain barrier (BBB).

Metabolized in the liver in three main ways: conjugation with glucuronides, conjugation with sulfates, oxidation by microsomal liver enzymes. In the latter case, toxic intermediate metabolites are formed, which are subsequently conjugated with glutathione, and then with cysteine and mercapturic acid. The main isoenzymes of cytochrome P450 for this metabolic pathway are the isoenzyme CYP2E1 (mainly), CYP1A2 and CYP3A4 (minor role). With glutathione deficiency, these metabolites can cause damage and necrosis of hepatocytes.

Additional metabolic pathways include hydroxylation to 3-hydroxyparacetamol and methoxylation to 3-methoxyparacetamol, which are subsequently conjugated to glucuronides or sulfates.

Conjugated metabolites of paracetamol (glucuronides, sulfates and conjugates with glutathione) have low pharmacological (including toxic) activity. T1/2 - 1-4 hours. Excreted by the kidneys in the form of metabolites, mainly conjugates, only 3% unchanged.

In elderly patients, drug clearance decreases and T1/2 increases.

Pheniramine

Well absorbed in the digestive tract. T1/2 from blood plasma is from 1 to 1.5 hours. It is excreted from the body mainly through the kidneys.

Ascorbic acid

Well absorbed in the digestive tract. The time to create the maximum therapeutic concentration (TCmax) after oral administration is 4 hours. Metabolized primarily in the liver. It is excreted by the kidneys, through the intestines, with sweat, unchanged and in the form of metabolites.

Plasma protein binding - 25%. Easily penetrates into leukocytes, platelets, and then into all tissues, the highest concentration is achieved in the glandular organs, leukocytes, liver and lens of the eye, penetrates the placental barrier. The concentration of ascorbic acid in leukocytes and platelets is higher than in erythrocytes and plasma. In deficiency states, leukocyte concentrations decline later and more slowly and are considered a better measure of deficiency than plasma concentrations.

Metabolized primarily in the liver into deoxyascorbic acid and further into oxaloacetic acid and ascorbate-2-sulfate.

It is excreted by the kidneys, through the intestines, with sweat, breast milk unchanged and in the form of metabolites. Excreted during hemodialysis.

Indications for Fervex®

As a symptomatic therapy for acute respiratory viral infections to relieve the following symptoms:

rhinorrhea, nasal congestion, headache, fever, lacrimation, sneezing. ICD-10 codes

Dosage regimen

Orally, 1 sachet 2-3 times/day. Before use, the contents of the sachet must be dissolved in a glass (200 ml) of warm water. The maximum duration of treatment is 5 days.

The maximum daily dose of paracetamol for a body weight of more than 50 kg should not exceed 4 g (or 8 sachets of Fervex®), in children or patients weighing 40-50 kg, the maximum daily dose of paracetamol should not exceed 3 g, for a body weight of less than 40 kg - no more than 2 g.

The interval between doses of the drug should be at least 4 hours.

In patients with impaired renal function (creatinine clearance (CC) <.10 ml/min), the interval between doses of the drug should be at least 8 hours.

In patients with chronic or decompensated liver diseases, in patients with liver failure, chronic alcoholism, in malnourished patients and in cases of dehydration, the daily dose of paracetamol should not exceed 3 g.

The drug should not be taken for more than 3 days as an antipyretic and for more than 5 days as an analgesic.

If there is no relief of symptoms within 5 days after starting to take the drug, the body temperature remains elevated, or after an initial decrease it suddenly rises again, the patient should consult a doctor.

Side effect

The drug is well tolerated in recommended doses. When using the drug, the following side effects were observed (frequency not established).

From the hematopoietic system: anemia, leukopenia, agranulocytosis, thrombocytopenia.

From the immune system: allergic reactions (erythema, skin rash, itching, Quincke's edema, anaphylactic shock).

From the nervous system: drowsiness, confusion, hallucinations, impaired concentration (more often in elderly patients), agitation, nervousness, insomnia, coordination dysfunction, tremor.

On the part of the organ of vision: disturbance of accommodation.

From the cardiovascular system: palpitations, orthostatic hypotension, dizziness.

From the digestive system: dry mouth, nausea, vomiting, abdominal pain, constipation.

From the urinary system: difficulty urinating.

If adverse reactions occur, the patient should stop taking the drug and consult a doctor.

Contraindications for use

erosive and ulcerative lesions of the gastrointestinal tract (in the acute phase), liver failure, angle-closure glaucoma, urinary retention associated with prostate diseases and urinary disorders, portal hypertension, alcoholism, phenylketonuria, glucose-galactose malabsorption, sucrase/isomaltase deficiency, fructose intolerance, children age (up to 15 years), pregnancy (safety has not been studied), lactation (safety has not been studied), hypersensitivity to paracetamol, ascorbic acid, pheniramine or any other component of the drug.

With caution: renal failure, congenital hyperbilirubinemia (Gilbert, Dubin-Johnson and Rotor syndromes), viral hepatitis, alcoholic hepatitis, old age, diabetes mellitus.

Use during pregnancy and breastfeeding

There have been no adequate and well-controlled studies of Fervex® in pregnant women, so the use of the drug in this group of patients is not recommended.

It is not known whether the active substances of the drug pass into breast milk. The drug should not be used during lactation.

Use for liver dysfunction

The drug should be used with caution in case of liver failure, congenital hyperbilirubinemia (Gilbert, Dubin-Johnson and Rotor syndromes), viral hepatitis, alcoholic hepatitis.

Use for impaired renal function The drug should be used with caution in case of renal failure.

Use in children The use of the drug in children under 15 years of age is contraindicated.

Use in elderly patients The drug should be used with caution in elderly patients.

special instructions

Fervex® should not be used simultaneously with other drugs containing paracetamol.

To avoid toxic liver damage, paracetamol should not be combined with alcoholic beverages, or taken by persons prone to chronic alcohol consumption.

The risk of developing liver damage increases in patients with alcoholic hepatosis.

If the recommended doses are exceeded and with prolonged use, mental dependence on the drug may appear.

To avoid an overdose of paracetamol, you should ensure that the total daily dose of paracetamol contained in all medications taken by the patient does not exceed 4 g.

Ascorbic acid as a reducing agent can distort the results of various laboratory tests (blood and urine glucose, bilirubin, liver transaminase and LDH activity).

If the drug is taken by patients with diabetes or on a low-sugar diet, it should be taken into account that each sachet contains 11.555 g of sucrose, which corresponds to 0.9 XE.

Impact on the ability to drive vehicles and operate machinery

Considering the possibility of developing undesirable effects such as drowsiness and dizziness, it is recommended to refrain from driving a car or using machinery during treatment with the drug.

Overdose

Symptoms due to paracetamol

In case of overdose, intoxication is possible, especially in elderly patients, children, patients with liver diseases (caused by chronic alcoholism), in patients with malnutrition, as well as in patients taking inducers of microsomal liver enzymes, in which fulminant hepatitis, liver failure, cholestatic hepatitis, in the above cases - sometimes fatal. The overdose threshold may be lower in these categories of patients. The clinical picture of acute overdose develops within 24 hours after taking paracetamol.

Symptoms: gastrointestinal disorders (nausea, vomiting, loss of appetite, abdominal discomfort and (or) abdominal pain), pale skin. When administered simultaneously to adults of 7.5 g or more or to children of more than 140 mg/kg, cytolysis of hepatocytes occurs with complete irreversible liver necrosis, the development of liver failure, metabolic acidosis and encephalopathy, which can lead to coma and death. 12-48 hours after the administration of paracetamol, there is an increase in the activity of microsomal liver enzymes, lactate dehydrogenase, bilirubin concentration and a decrease in prothrombin concentration. Clinical symptoms of liver damage appear 2 days after an overdose of the drug and reach a maximum on days 4-6.

Treatment: immediate hospitalization. Determination of the quantitative content of paracetamol in blood plasma before starting treatment as early as possible after an overdose. Administration of SH-group donors and precursors of glutathione synthesis - methionine and acetylcystine - is most effective in the first 8 hours. The need for additional therapeutic measures (further administration of methionine, intravenous administration of acetylcysteine) is determined depending on the concentration of paracetamol in the blood, as well as time elapsed after its introduction. Symptomatic treatment. Laboratory tests of the activity of microsomal liver enzymes should be carried out at the beginning of treatment and then every 24 hours. In most cases, the activity of microsomal liver enzymes normalizes within 1-2 weeks. In very severe cases, a liver transplant may be required.

Symptoms caused by the action of ascorbic acid

Symptoms: nausea, diarrhea, irritation of the gastrointestinal mucosa, flatulence, spastic abdominal pain, frequent urination, nephrolithiasis, insomnia, irritability, hypoglycemia.

Treatment: Stop using the drug immediately and consult a doctor. Treatment is symptomatic, forced diuresis.

Symptoms caused by the action of pheniramine

Symptoms: convulsions, disturbances of consciousness, coma.

Treatment: Stop using the drug immediately and consult a doctor. It is recommended to lavage the stomach, take enterosorbents (activated carbon, hydrolytic lignin), intravenous or oral administration of the antidote acetylcysteine (if possible, in the first 10 hours after an overdose), and symptomatic treatment.

Drug interactions

Ethanol enhances the sedative effect of antihistamines (pheniramine), so its use should be avoided during treatment with Fervex®. In addition, ethanol, when used simultaneously with pheniramine, contributes to the development of acute pancreatitis.

Pheniramine enhances the effect of sedatives: morphine derivatives, barbiturates, benzodiazepines and other tranquilizers, neuroleptics (meprobamate, phenothiazine derivatives), antidepressants (amitriptyline, mirtazapine, mianserin), centrally acting antihypertensive drugs, sedatives belonging to the group of histamine H1 receptor blockers, baclofen, this not only increases the sedative effect, but also increases the risk of developing side effects of the drug (urinary retention, dry mouth, constipation).

The possibility of enhancing central m-anticholinergic effects when used in combination with other drugs with m-anticholinergic activity (other histamine H1 receptor blockers, tricyclic antidepressants, phenothiazine neuroleptics, antispasmodics and antiparkinsonian drugs with m-anticholinergic activity, disopyramide) should be taken into account.

When using the drug together with inducers of microsomal oxidation: barbiturates, tricyclic antidepressants, anticonvulsants (phenytoin), flumecinol, phenylbutazone, rifampicin and ethanol, the risk of hepatotoxicity (due to paracetamol included in the composition) significantly increases.

GCS, when used simultaneously, increases the risk of developing glaucoma.

Concomitant use with salicylates increases the risk of nephrotoxicity.

When used simultaneously with chloramphenicol (chloramphenicol), the toxicity of the latter increases.

Paracetamol enhances the effect of indirect anticoagulants and reduces the effectiveness of uricosuric drugs.

Ascorbic acid increases the concentration of benzylpenicillin and tetracyclines in the blood, and at a dose of 1 g/day increases the bioavailability of ethinyl estradiol (including that included in oral contraceptives).

Ascorbic acid improves the absorption of iron preparations in the intestines (converts ferric iron to divalent iron), and can increase the excretion of iron when used simultaneously with deferoxamine.

Ascorbic acid reduces the effectiveness of heparin and indirect anticoagulants.

When used simultaneously with acetylsalicylic acid (ASA), the urinary excretion of ascorbic acid increases and the excretion of ASA decreases. ASA reduces the absorption of ascorbic acid by approximately 30%. Increases the risk of developing crystalluria during treatment with salicylates and short-acting sulfonamides, slows down the excretion of acids by the kidneys, increases the excretion of drugs that have an alkaline reaction (including alkaloids), and reduces the concentration of oral contraceptives in the blood.

Ascorbic acid increases the overall clearance of ethanol, which in turn reduces the concentration of ascorbic acid in the body.

Quinoline drugs, calcium chloride, salicylates, corticosteroids, when used for a long time, deplete ascorbic acid reserves.

When used simultaneously, ascorbic acid reduces the chronotropic effect of isoprenaline.

With long-term use or use in high doses, ascorbic acid may interfere with the interaction of disulfiram and ethanol.

In high doses, ascorbic acid increases the excretion of mexiletine by the kidneys.

Barbiturates and primidone increase the excretion of ascorbic acid in the urine.

Ascorbic acid reduces the therapeutic effect of neuroleptics - phenothiazine derivatives, tubular reabsorption of amphetamine and tricyclic antidepressants.

Storage conditions for Fervex®

The drug should be stored out of the reach of children at a temperature of 15° to 25°C.

Shelf life of Fervex® Shelf life - 3 years. Do not use the drug after the expiration date indicated on the package.

Terms of sale The drug is available without a prescription.

Fervex price, where to buy

The price of Fervex for children starts from 250 rubles.

The price of Fervex (1 sachet) varies between 25-35 rubles.

Online pharmacies in RussiaRussia
Online pharmacies in UkraineUkraine
Online pharmacies in KazakhstanKazakhstan

ZdravCity

Fervex powder for intravenous injection solution.
approx. with sah. raspberries 13.1g 8 pcs. Bristol-Myers Squibb/UPSA SAS RUR 333 order
Fervex powder for intravenous injection solution. approx. with sah. lemon 13.1g 8 pcs. Bristol-Myers Squibb/UPSA SAS
RUB 334 order
Fervex for children powder for injection solution for internal use. approx. raspberry 8 pcs.UPSA SAS
RUB 295 order